crossover randomized trial

S003098

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Other conditionsS003098

Design

Randomized: 8
Start year
Treatment: 0.02 weeks
Countries: United Kingdom (1 sites)
Sponsor: (mixed)
Eligibility: healthy nondiabetic men

Conduct and analysis

Blinding: double blind
Sequence generation: other adequate
Allocation concealment: not reported
Outcome adjudication: not reported
Primary estimand: not stated
Analysis population
Missing data

Arms

Arm	Treatment	Background	Randomized	Analyzed	Completed treatment
A1	exenatide Exenatide 5 ug single dose	lifestyle: not reported	8
A2	Placebo Placebo single dose	lifestyle: not reported	8

Baseline characteristics

As printed in the trial reports or registry, per arm or for the whole trial.

Characteristic	Statistic	Whole trial ALL
age	mean (years)	35.3
age	sd (years)	6.3
bmi	mean (kg/m2)	24.7
bmi	sd (kg/m2)	1.7
other male	n	8

Results

2 adjudicated result lines, grouped by outcome. Open an outcome to see its values.

Nausea (1 lines; O27A)

Week	Arm	Statistic	Estimate	SE or SD	95% CI	Events / N	Detail
	A1	events				1 / 8	not stated; randomized; R0027056:p3

Vomiting (1 lines; O27B)

Week	Arm	Statistic	Estimate	SE or SD	95% CI	Events / N	Detail
	A1	events				1 / 8	not stated; randomized; R0027056:p3